Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
MBCC 12
16 - 18 Jun 2010
Erice, Italy
Tumours are highly dynamical diseases characterised by multiple scales ranging from molecular to macroscopic events. The complexity of the most recent clinical-genomic tumor-related data in the age of Molecular Medicine implies that biostatistics and even bioinformatics analyses are no more sufficient to cope with such data in order to explain them as well as to produce useful predictions. Mechanistic models of biomedical phenomena with complex outputs must be built, in order to open the road for tailored therapies and to bridge the bench to the bedside. This represents a huge challenge at the frontier of the contemporary mathematical modelling. This conference will gather top-level worldwide scientists, who work on the most advanced frontiers of mathematical oncology and who have a strong awareness of the biomedical problems, as well as some experimental and clinical scientists who are particularly aware of (and trusting in) dynamics modeling in bio-medicine.
Defining molecular profiles on circulating tumour cells
Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital, Ital...
Breast imaging with MRI: how to use?
Dr Pietro Panizza - Università Vita Salute San Raffaele, Milan, Italy
Potentially useful treatment proposals for predisposition breast cancer gene car...
Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, USA
Spotlight on circulating tumour cells
Dr Richard Cote - University of Miami, Miami, USA
New endocrine agents for prevention of breast cancer
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Update of the NSABP STAR trial: preventing breast cancer
Dr Leslie Ford - National Cancer Institute, Bethesda, USA
High-risk genes for breast cancer: the genetic 'Foucault pendulum'
Dr Judy Garber - Dana-Farber Cancer Institute, Boston, USA
The impact of lifestyle on breast cancer risk
Dr Pamela Goodwin - Mount Sinai Hospital, Toronto, Canada
Androgen receptors: prognostic and therapeutic relevance
Dr Antonio Wolff - The Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
PET scans in staging and treatment of breast cancer
Prof Norbert Avril - Barts and The London School of Medicine and Dentistry, Lond...
High risk clinic: follow-up of healthy individuals with genetic predisposition t...
Dr Bernardo Bonanni - European Institute of Oncology, Milan, Italy
MRI and ultrasound dynamic coregistration
Dr Alfonso Fausto - San Giovanni di Dio General Hospital, Gorizia, Italy
Metabolic syndrome and breast cancer prevention
Dr Andrea Decensi - Galliera Hospital, Genoa, Italy
Issues affecting Indian breast cancer treatment
Dr. Siddharth Ramesh Sahni - Artemis Health Institute, New Delhi, India
Cancer prevention and treatment in India
Prof Goura Kishor Rath - All India Institute of Medical Sciences, New Delhi, Ind...
Anti-angiogenic therapy as treatment for breast cancer
Dr Francesco Bertolini - European Institute of Oncology, Milan, Italy